Pre-Open Stock Movers:
NeoGenomics, Inc. (NASDAQ:NEO) 29% LOWER; CEO Mark Mallon to step down. Expects revenue for Q1 2022 may be below the low end of its prior guidance of $118 - $120 million and EBITDA for Q1 2022 will be below the low end of its prior guidance of $(15) - $(12) million.
Nielsen Holdings plc (NYSE:NLSN) 22% HIGHER; agreed to be acquired by a private equity consortium led by Evergreen Coast Capital Corporation, an affiliate of Elliott Investment Management L.P., and Brookfield Business Partners (NYSE:BBU) L.P. together with institutional partners for $28 per share in an all-cash transaction valued at approximately $16 billion, including the assumption of debt.
Progenity, Inc. (Nasdaq: PROG) 22% LOWER; Net loss was $92.9 million for the three months ended December 31, 2021 and net loss per share was $0.56, compared to net loss of $43.7 million and net loss per share of $0.46 for the three months ended September 30, 2021.
The Lovesac Company (NASDAQ:LOVE) (LOVE) 16% HIGHER; reported Q4 EPS of $2.03, $1.49 better than the analyst estimate of $0.54. Revenue for the quarter came in at $196.2 million versus the consensus estimate of $174.33 million.
Vertical Aerospace (EVTL) 12% HIGHER; Avolons announcement today that it has exceeded its whole 500 unit pre-order of Verticals VX4 electric aircraft within nine months. Avolon, the world's second largest aircraft lessor, pre-ordered 500 VX4s in June 2021, and as of today has placed all of these units, as well as an additional 50 aircraft options, with leading global airlines.
Conn's (NASDAQ:CONN) (CONN) 11% LOWER; reported Q4 EPS of $0.33, $0.15 worse than the analyst estimate of $0.48. Revenue for the quarter came in at $402.5 million versus the consensus estimate of $412.22 million.
Lightning eMotors (ZEV) 10% LOWER; reported Q4 EPS of $0.28, may not compare to the analyst estimate of ($0.19). Revenue for the quarter came in at $4.22 million versus the consensus estimate of $5.25 million. Lightning eMotors sees Q1 2022 revenue of $5-6 million, versus the consensus of $10.4 million.
Ginkgo Bioworks (DNA) 9% HIGHER; reported Q4 EPS of ($1.10), $1.06 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $148.5 million versus the consensus estimate of $94.81 million. Ginkgo Bioworks sees FY2022 revenue of $325-340 million, versus the consensus of $305.8 million.
LHC Group (NASDAQ:LHCG) 7% HIGHER; agreed to be acquired by UnitedHealth Group's (NYSE:UNH) Optum for $170 per share.
Pear Therapeutics (PEAR) 6% HIGHER; reported Q4 EPS of $0.13, $0.54 better than the analyst estimate of ($0.41). Revenue for the quarter came in at $1.32 million versus the consensus estimate of $1.47 million. Pear Therapeutics sees FY2022 revenue of $22 million
AEye (LIDR) 6% LOWER; reported Q4 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $600 thousand. AEye sees FY2022 revenue of $4-6 million.
IONQ Inc (IONQ) 2% HIGHER; reported Q4 EPS of ($0.39), $0.29 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.6 million versus the consensus estimate of $1.14 million. IONQ Inc sees FY2022 revenue of $10.2-10.7 million.
FedEx Corp. (NYSE:FDX) 2% HIGHER; Founder Frederick Smith to step down as CEO, naming Raj Subramaniam as the new CEO.
Pinterest Inc (NYSE:PINS) 2% LOWER; Morgan Stanley (NYSE:MS) downgraded from Overweight to Equalweight and set a $30 price target.
CVS Health (NYSE:CVS) (CVS) 1% LOWER; Deutsche Bank (DE:DBKGn) downgraded from Buy to Hold with a price target of $110.
Etsy (NASDAQ:ETSY) (ETSY) 1% LOWER; Loop Capital downgraded from Buy to Hold with a price target of $140.